Neurocrine Bioscience buy tamam
Start price
25.08.15
/
50%
€40.64
Target price
21.09.15
€49.99
Performance (%)
23.60%
End price
21.09.15
€50.22
Summary
This prediction ended on 21.09.15 with a price of €50.22. The BUY prediction by tamam finished with a performance of 23.60%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Neurocrine Bioscience | 2.432% | 2.432% | 38.006% | 75.098% |
| iShares Core DAX® | 4,57 % | 4,14 % | 7,35 % | 57,58 % |
| iShares Nasdaq 100 | 1,83 % | -1,64 % | 33,64 % | 88,08 % |
| iShares Nikkei 225® | -0,29 % | 2,47 % | 60,45 % | 76,67 % |
| iShares S&P 500 | 2,23 % | 0,71 % | 24,13 % | 66,11 % |
Comments by tamam for this prediction
In the thread Neurocrine Bioscience diskutieren
tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
tamam stimmt am 25.08.2015 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 55.42€ zu.
With Phase 3 data in tardive dyskinesia and Phase 1/2 data in Tourette syndrome with NBI-98854, Phase 3 data in endometriosis and Phase 2b data in uterine fibroids with elagolix, and Phase 1/2 data with NBI-77860 in congenital adrenal hyperplasia.
(Vom Mitglied beendet)
Stopped prediction by tamam for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€77.15
23.02.18
23.02.18
€112.75
04.11.21
04.11.21
6.34%
05.11.21
05.11.21
